News

Correction to EIC Pathfinder Open 2026 Call

Published on | 1 hour ago

Programmes
EIC

The EIC Pathfinder Open 2026 call was published with incorrect settings on 05/02/2026, specifically requiring an update to the HORIZON Lump Sum Grant model.

A technical update is being carried out and it is excepted that the portal will have correct information shortly. This correction will not change the call's scope, objectives, eligibility conditions, or evaluation criteria.

However, applicants who have begun their proposals will need to restart the submission process to meet the updated call conditions. Notifications will be sent to affected applicants once the portal is corrected. Further details will be provided on the official website as they become available.

Applicants should monitor the official portal for updates and prepare to restart their submissions once notified!

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1794 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.